IPO

Evoq Remedies Limited IPO

BSE SME

Listed On: Mar 30, 2022 at ₹ 25.0

₹ 216000 /8000 Shares
*Min Investment

Check Allotment

17 Mar, 2022

Open Date

22 Mar, 2022

Close Date

28 Mar, 2022

Allotment Date

30 Mar, 2022

Listing Date
IPO Issue Details
  • Issue Price ₹27 per equity share
  • Face Value ₹10 Per Equity Share
  • Issue Price 3,600,000 Eq Shares of ₹10(aggregating up to ₹9.72 Cr)
  • Listing at BSE SME
  • List Price 25.0
  • Listing Date 2022-03-30
  • Lead Manager Swastika Investmart Ltd
  • Registrar Bigshare Services Pvt Ltd
IPO Details
  • Retail Portion N/A
IPO Documents
IPO Details


Evoq Remedies Limited IPO is an SME IPO, priced at ₹27 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the BSE SME platform.

The IPO bidding window is open from Mar 17, 2022 to Mar 22, 2022. The allotment is expected to be finalized on Mar 28, 2022, and the tentative listing date is Mar 30, 2022.


The registrar of the IPO is Bigshare Services Pvt Ltd, and

Read More
IPO Subscription Analysis And Details
Retail
3.03x
Total
1.67x
As onQIB / NIIRetailTotal
Shares Offered / Reserved1,710,0001,710,0003,420,000
Day 1 17-03-22 06:00 PM
0.11 x0.26 x0.19 x
Day 2 21-03-22 06:00 PM
0.27 x1.12 x0.70 x
Day 3 22-03-22 06:00 PM
0.30 x3.03 x1.67 x
Valuations
Earnings Per Share (EPS) ₹N/A/-
P/E Ratio N/A
RoNW N/A%
Net Asset Value (NAV) - Post Issue ₹N/A/-
Company Financials
In Crs.
In Cr.
1-Feb-2231-Mar-2131-Mar-2031-Mar-19
Assets26.608.045.652.14
Revenue10.5610.029.073.25
Profit After Tax0.930.710.0030.01
About Company

Incorporated in 2010, EVOQ Remedies Limited specializes in offering quality Pharmaceuticals Raw Material products, Excipients, and Bulk Drugs at an affordable prices. The company procures all the products from WHO-GMP certified & reliable Manufacturers & Importers, who follow procedures as per the stringent national and international quality and safety standards.

Read More
- Promoter(s)

Mr. Bhumishth Narendrabhai Patel

Mrs. Payal Bhumishth Pate

Pre Issue Share Holding : 99.99%

Post Issue Share Holding : 73.53%

IPO - Issue Objectives
1

To Meet Incremental Working Capital Requirements.

2

Meet issue related expense.

3

General Corporate Purpose.